Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Initial Sale of Non-Core Assets

27 Feb 2013 17:07

RNS Number : 8294Y
J.P. Morgan Private Equity Ltd
27 February 2013
 



 

JPEL ANNOUNCES INITIAL SALE OF NON-CORE ASSETS

 

* * *

 

GUERNSEY, 27 FEBRUARY 2013

 

Pursuant to J.P. Morgan Private Equity Limited's ("JPEL" or the "Company") announcement of its Strategic Initiatives on 7 November 2012, JPEL entered into a binding agreement to sell interests in four US and European based buyout funds ("Initial Sale Portfolio") with vintages predominantly in the 2005-2006 range. The secondary sale was completed with three third-party buyers at an aggregate discount of 15% to prevailing NAV. The transaction will generate cash proceeds of approximately $27.8 million and will also release JPEL from approximately $2.4 million in unfunded commitments.

 

Proceeds will be used entirely to reduce the Company's leverage. The sale will be reflected in JPEL's February 2013 NAV as the values for the Initial Sale Portfolio will be adjusted to reflect the agreed sale price.

 

The Company will continue to execute its plans as outlined in its Strategic Initiatives announcement in November 2012. Since making the announcement, JPEL has:

 

·; Returned $20 million to US$ Equity Shareholders by repurchasing 31,372,548 US$ Equity Shares at a 42.6% discount to prevailing NAV; and

·; Sold approximately $32.9 million of assets, generating $27.8 million of immediate cash proceeds, representing a 15% discount to NAV.

 

 

The Company will continue to attempt to capitalise on the disconnect between its US$ Equity Share price and the value of its underlying assets while simultaneously reducing outstanding leverage and cost of capital. The Company is due to pay the capital entitlement on the Company's 2013 Zero Dividend Preference Shares, which becomes due on 28 April 2013, and is also exploring the sale of several other non-core, pre-credit crisis assets in the secondary market. JPEL anticipates making further announcements regarding any potential sales in due course.

 

* * *

 

This communication does not constitute an offer or invitation or solicitation to make an offer by or on behalf of the Company or any of its affiliates, directors, officers, employees or shareholders to buy, sell or enter into an agreement for the sale or purchase of shares or any of the businesses or assets described herein.

 

This communication is not and should not be taken as constituting the giving of investment advice by the Company or its managers to any recipient.

 

Past performance is not a guide to future performance and the value of investments and the income derived from those investments can go down as well as up. Future returns are not guaranteed and a total loss of principal may occur.

 

Recipients of this communication are recommended to seek their own independent legal, tax, financial and other advice and should rely solely on their own judgment, review and analysis in evaluating the Company, its business and its affairs.

 

This document includes statements that are, or may be deemed to be, "forward-looking statements". In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual performance, results of operations, internal rate of return, financial condition, liquidity, distributions to shareholders and the development of its financing strategies may differ materially from the impression created by the forward-looking statements contained in this document

 

 

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Gregory Getschow

+1 212 648 1150

Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISPGUQAPUPWGQM
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.